•
PR
PRQR
ProQR Therapeutics N.V. Ordinary Shares
polygon--
Price Chart
Market Cap
172.77M
Volume
242.46K
52W High
$3.10
52W Low
$1.07
Open
$1.64
Prev Close
$1.64
Day Range
1.64 - 1.75
About ProQR Therapeutics N.V. Ordinary Shares
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
Latest News
ProQR to Participate in 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.•Dec 1
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
GlobeNewswire Inc.•Oct 20
ProQR Announces First Quarter 2025 Operating and Financial Results
GlobeNewswire Inc.•May 8
ProQR Announces Year End 2024 Operating and Financial Results
GlobeNewswire Inc.•Mar 13
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
GlobeNewswire Inc.•Dec 10
ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
GlobeNewswire Inc.•Oct 25
ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement
GlobeNewswire Inc.•Oct 23
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
GlobeNewswire Inc.•Oct 7